
University of Hawaii. Licensing e proof of concept.
In the debate surrounding the Bio-On case, one statement has repeatedly resurfaced in different forms: the technology did not exist. It is a categorical claim, and precisely for that reason, it should be measured against what universities, technology transfer offices, and laboratories actually do when they believe a technology exists sufficiently to be licensed. Universities do not grant exclusive global licenses for vague ideas. They grant rights to patented inventions, described processes, and laboratory results that a technology transfer office has already assessed as transferable. This is not a guarantee of success. It is, however, a formal act: an institution with its own rules and a public mandate has decided that this body of knowledge is valuable enough to be brought to market. The question, therefore, is much simpler: if the technology did not exist, why did the University of Hawaii license it, renew its collaboration for years, and accept new research funding?
Who is Prof. Jian Yu
Prof. Jian Yu is a biochemical engineer. He graduated in China, earned his PhD from the University of British Columbia in 1991, taught in Hong Kong and, since 2001, has worked at the Hawaii Natural Energy Institute of the University of Hawaii at Mānoa, within the School of Ocean and Earth Science and Technology. His field is not corporate communications. It is bioprocess engineering: biomass pretreatment, microbial fermentation, bioreactor design, green chemistry, and the production of plastics and fuels from renewable sources. Yu's public HNEI curriculum lists dozens of peer-reviewed articles and patents subsequently licensed to companies.
The starting point of his research into PHAs is concrete. Hong Kong first, and Hawaii later, share a problem: organic waste, limited space, and the ocean nearby. Yu works on a process in which microorganisms convert waste — molasses, biodiesel-derived glycerol, beet pulp, food waste, and later lignocellulosic materials — into polyhydroxyalkanoates, biopolymers that behave like petroleum-based plastics but degrade into carbon dioxide and water.
This is not an isolated discovery. PHAs have been known since Maurice Lemoigne's demonstration in 1926. What Yu patents and scales is a process pathway: how to feed bacteria with low-cost raw materials, how to design the fermenter, how to recover the polymer, and how to approach the transition from the laboratory to a pilot plant.
Before Bio-On: the 2003 license
In March 2003, the Office of Technology Transfer and Economic Development of the University of Hawaii (UH) signed a licensing agreement with a Hong Kong company. The subject was a UH-patented technology, developed by Yu, that used fermentation to convert organic waste into bioplastics and organic fertilizers. The license was territorial: Hong Kong, Macau, and the People's Republic of China. It provided for an upfront fee, royalties on sales, sublicensing rights, and reimbursement of patent prosecution costs.
The university, in other words, was not simply "lending its name." It was transferring rights to an invention that it considered sufficiently described to be exploited by an industrial entity, in exchange for compensation and subject to development obligations. This precedent is important in framing our case for one simple reason: when Bio-On entered into a relationship with UH several years later, it was approaching a group that had already travelled the path from paper to patent, from patent to license, and from license to pilot design.
There is also a human detail, absent from the press releases but useful in understanding why that collaboration lasted. Yu agreed to work with an Italian group, and to come to Italy, because he considered our country a global reference point for industrial fermentation: a tradition stretching from wineries and dairies to fine chemicals and antibiotics. For a researcher who spent his life working on bioreactors, this was not folklore. It was a technical criterion. If he was going to leave the laboratory in Honolulu and see a process take shape in an industrial setting, Italy seemed to him the right place.
What a university license actually is
A technology-transfer license is not limited to the issuing of a press release. It is a contract. The university remains the owner of the patent. The licensee obtains the right — exclusive or non-exclusive, territorial or global — to use, develop and, in certain cases, sublicense that technology. In return, it pays money directly or funds further research, and commits to commercializing the technology or, at the very least, to not letting the intellectual property remain dormant.
For a start-up, this model serves a precise purpose. It does not have to reinvent a technology, but acquires an already protected foundation on which to bring it into a different industrial context, add its own know-how and, if operating under an intellectual-property business model, resell third parties the right to use the process (IP business model).
In the Bio-On case, public university documents and 2015 press releases state three things, all verifiable:
Yu's curriculum lists the projects, with amounts and dates: PHA production from beet pulp, sugar-cane molasses, crude glycerol, the design of a pilot fermentation and recovery plant, and finally the 2015–2020 PHA-from-biomass program. Alongside the contracts are technical reports addressed to Bio-On S.r.l., Bologna: not interviews, but project reports.
Proof of concept: what was actually being demonstrated
"Proof of concept" is an overused expression. In process engineering, it means something more specific and more modest: demonstrating that a laboratory concept survives the first step in scale-up. It is not yet ready for a factory, but it is the stage at which researchers determine whether the strain, the medium, the bioreactor and the polymer-recovery process hold together outside the flask.
In the UH–Bio-On pathway, this proof developed on several levels, none of which should be confused with full-scale production:
UH Mānoa Chancellor Robert Bley-Vroman, in the 2015 press release, spoke of a material with scientific and industrial potential and accepted the investment in the HNEI laboratories. Yu, in the same announcement, linked the new funding to "a successful collaboration on several projects over the past seven years."
These statements do not establish that the Italian business plan was sound, that the PHA market was mature, or that the ramp-up at Castel San Pietro would proceed smoothly. They do, however, document beyond dispute that the university holding the patents continued to work with the licensee and continued to accept funding to do so.
What a license does not prove
It should be stated with equal clarity that a university license does not certify stock-market value. Nor does it guarantee that a plant designed to produce thousands of tonnes per year will start on time. It does not replace customers, working capital, or sound governance.
Nor can one infer from the license whether the licensing revenues recorded in the financial statements were accounted for correctly: that is a separate issue that we will examine later and which deserves dedicated articles.
The license between UH and Bio-On demonstrates that the premise "the technology did not exist" conflicts with public acts and records of a U.S. university: patents, a technology transfer office, multi-year research agreements, project reports, reciprocal visits, and a second investment of $1.4 million in mid-2015.
The existence of a technology and the success of a company are two different questions. Confusing them is the quickest way to understand neither.
A minimum timeline, for orientation
2001 — Yu joins HNEI. The research focus already includes the conversion of waste into PHAs.
2003 — UH licenses the technology to I-PHA BioPolymers for China, Hong Kong and Macau. The project refers to a pilot plant and to Yu as chief scientist.
Around 2008 — according to UH and Bio-On sources, the collaboration with the Italian company begins. Around the same period, Yu produces reports on PHA production from beet pulp.
2009–2013 — reports for Bio-On on pilot systems, molasses and glycerol. Yu visits Minerbio. Funding accumulated to $1.6 million over seven years, according to UH.
September 1, 2015 — exclusive global research agreement worth $1.4 million. UH confirms the exclusive global license to two patents concerning bioplastics made from household waste.
2015–2020 — in Yu's CV, the "PHA bioplastics from biomass" project lists Bio-On as the funder, with $1,419,011 in funding.

pict 24_ slide show impianto pilota Bio-On Minerbio (dal 2010)
A conclusion, for now, based solely on the documents
If the technology had not existed, the University of Hawaii would have had nothing to license in 2003, nothing to extend to an Italian licensee, and nothing to fund again in 2015. A university can certainly get a market forecast wrong, but it does not ordinarily sign exclusive global licenses and multi-million-dollar research agreements without a concrete technical basis. The collaboration with Prof. Yu does not, by itself, resolve every question surrounding the Bio-On case. But it certainly helps frame the matter from the correct starting point: a real technology, at an intermediate stage between laboratory research and industrial application, on which a university had placed its name and its patents. Everything else — plants, accounts, the market, short sellers, the legal proceedings — comes afterward. And it should be read afterward.
Documenti e fonti consultabili
01_Comunicato University of Hawaiʻi System News, 10 settembre 2015: Researcher's work in bioplastics leads to $1.4 million contract.
02_Comunicato UH, 3 marzo 2003: UH Signs Technology License Agreement with I-PHA BioPolymers Ltd. of Hong Kong.
03_Curriculum vitae pubblico di Jian Yu, Hawaii Natural Energy Institute (progetti, importi, report a Bio-On).
04_bioplastics MAGAZINE, 1° settembre 2015; Hawaii Business Magazine, novembre 2015; comunicato congiunto Bio-On / UH del 1° settembre 2015.
05_ Attachments published in the article #02: licenza Università delle Hawaii (8 febbraio 2008, versione pubblica); CV e brevetti di Jian Yu; Documento di Ammissione AIM, parte tecnica.
06_ presentazione UH tecnologia per BIO-ON (Bio-on 22Jan2010 ABSTRACT)
07_sviluppo tecnologia e impianto pilota MINERBIO Bologna ITALY (Techint MINERBIO-PHA - MASTER copia)
08_altri accordi con UH elenco completo
09_album fotografico di alcune foto dei laboratori UH per sviluppo prodotti BIO-ON
10_LINK OTTED
11_DOCUMETI INGEGNERISTICI TECHINT SVILUPPATI SU COLLABORAZIONE UH-BIO-ON 11.1 - 11.2 - 11.3 - 11.4
Who we are and who wrote this article
To understand the BIO-ON case in all its current relevance and complexity, one fact is worth keeping in mind: over the years, this story has been covered in thousands of articles, television reports, commentaries, and public debates. Far less attention, however, has been paid to the direct examination of the documents that accompanied the company's foundation, development, and subsequent events. This observation gave rise to an editorial project with a clear objective: to collect, organize, and make accessible the main documents relating to the BIO-ON case, accompanying them with informative articles designed to facilitate their reading and understanding.
The initiative, "Exploring the BIO-ON Case," prompted by a substantial number of former BIO-ON small investors, has brought together an editorial team of professionals with experience in different fields, including industry, academia, innovation, finance, law, scientific research, and communications. They contribute on a voluntary basis to the selection of sources, the verification of documentation, and the preparation of the articles. The editorial approach is simple: every in-depth analysis starts with the documents. For this reason, whenever possible, each article is accompanied by the original materials used, so that readers can consult them freely, directly, and at no cost, and form their own opinion.
The project does not seek to replace the work of the judicial authorities, regulatory and supervisory bodies, academics, or the media. Rather, it aims to provide a space in which documents, data, and sources can be examined with the time and attention that such a complex story deserves.